Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy
| Contribuinte(s) |
University of Aberdeen, Medicine, Medical Sciences & Nutrition, Other Applied Health Sciences |
|---|---|
| Data(s) |
03/10/2016
03/10/2016
23/09/2016
|
| Resumo |
Data access and analyses were funded by Boehringer Ingelheim, who played no role in the conduct or reporting of the study. Peer reviewed Publisher PDF |
| Identificador |
Halpin , D M G , Kerkhof , M , Soriano , J B , Mikkelsen , H & Price , D B 2016 , ' Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy ' Respiratory Research , vol 17 , 120 . , 10.1186/s12931-016-0433-5 1465-9921 PURE: 71318875 PURE UUID: bc268e19-7c21-47f0-b893-53090d040d2b PubMed: 27663386 |
| Idioma(s) |
eng |
| Relação |
Respiratory Research |
| Direitos |
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| Palavras-Chave | #randomised controlled trial #real-life research #chronic obstructive pulmonary disease #long-acting bronchodilators #R Medicine #R |
| Tipo |
Journal article |
